Related Experiment Video

Updated: Mar 13, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.3K

Epidermal growth factor receptor and notch signaling in non-small-cell lung cancer

Joanna Pancewicz-Wojtkiewicz1

  • 1Department of Histology and Embryology, Medical University of Bialystok, Bialystok, Poland.

Cancer Medicine
|October 23, 2016
PubMed

Insights

Understanding the crosstalk between epidermal growth factor receptor (EGFR) and Notch pathways is crucial for improving non-small-cell lung cancer therapy. This knowledge aids in optimizing treatments and predicting resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Lung cancer, particularly non-small-cell lung cancer (NSCLC), remains a leading cause of cancer mortality.
  • Current NSCLC treatment relies on TNM staging and histology, with limited improvement in patient prognosis.
  • Understanding cell signaling pathways is vital for advancing cancer therapy.

Purpose of the Study:

  • To review recent advances in the mechanisms of epidermal growth factor receptor (EGFR) and Notch signaling in NSCLC.
  • To evaluate the effectiveness of current targeted therapies for EGFR and Notch pathways in NSCLC.

Main Methods:

  • Literature review of recent scientific advances.
  • Focus on the interplay between EGFR and Notch signaling pathways.
  • Analysis of current therapeutic strategies targeting these pathways in NSCLC.

Main Results:

  • The crosstalk between EGFR and Notch signaling significantly influences NSCLC pathogenesis.
  • Targeted therapies for EGFR and Notch pathways show potential but require further optimization.
  • Understanding these pathways can improve patient screening and treatment selection.

Conclusions:

  • Elucidating the EGFR-Notch pathway crosstalk is essential for novel NSCLC therapeutic strategies.
  • Optimizing targeted therapies based on signaling pathway knowledge can improve patient outcomes.
  • Further research is needed to fully leverage these pathways for personalized NSCLC treatment.
Keywords:
Epidermal growth factor receptorNotchnon-small-cell lung cancertyrosine kinase inhibitors

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

496
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

9.3K

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.8K
Notch Signaling Pathway03:14

Notch Signaling Pathway

6.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K